Abattis Bioceuticals Corp ATTBF

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.

GREY:ATTBF - Post by User

Abattis Bioceuticals Corp

Bullboard Posts

Comment by Baymanon Aug 21, 2017 6:51pm

85 Views

Post# 26605308

RE:RE:RE:MOA's

Correct, but with the license, Experion no longer needs the millions from ATT. So the talks have gone nowhere at this point. And now it is doubtful they will go anywhere. Northern Vine owns 25% and I think that is the best it will get.

goldylocks1 wrote: Agreed. As long as they still have the option to do so. On the other hand, without a specific price agreed upon, I can't see abattis having much leverage. With a license, I would anticipate the asking price to have just gone up substantially.

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features